Oral versus intravenous methotrexate: Another opinion [3] (multiple letters)

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2283-2285

  Kamen, Barton A ^a   Winick, Naomi ^a   Holcenberg, John S ^a   Mahoney, Donald H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

COST CONTROL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG COST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LEUKOENCEPHALOPATHY; LYMPHOBLASTOMA; NEUROTOXICITY; PRIORITY JOURNAL; RELAPSE; REMISSION;

EID: 0031750170     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2283     Document Type: Letter

References (0)